Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Jason T. McConville"'
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 153:14-22
Tuberculosis is still one of the leading causes of death from a single infectious agent (i.e. Mycobacterium tuberculosis). First line therapy includes per oral administration of high doses of rifampicin over several months and is often times accompan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e26f0d73fb93c60449246aa184faa8e
https://doi.org/10.1016/j.ejpb.2020.05.007
https://doi.org/10.1016/j.ejpb.2020.05.007
Publikováno v:
Expert Opinion on Drug Delivery. 17:305-322
Introduction: Recently, tuberculosis was reported as the leading cause of death from a single infectious agent. Standard therapy includes administration of four first-line antibiotics, i.e. rifampicin, isoniazid, ethambutol, and pyrazinamide over a p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6169b7c4931c06d4a2e972574e3cd399
https://doi.org/10.1080/17425247.2020.1720644
https://doi.org/10.1080/17425247.2020.1720644
Publikováno v:
International journal of pharmaceutics. 590
Rifampicin is an antibiotic used in tuberculosis therapy showing extensive (solvato-) polymorphism. Per oral administration of high doses is recommended, but application as dry powder for inhalation at the site of infection being the lungs, is desira
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2040f3a4bdb1810cd34ae7856bee5540
https://pubmed.ncbi.nlm.nih.gov/33011253
https://pubmed.ncbi.nlm.nih.gov/33011253
Publikováno v:
Molecular pharmaceutics. 17(5)
The induction port (IP) for aerosol analysis with the Next Generation Pharmaceutical Impactor as monographed in the United States and European pharmacopoeia (USPIP) lacks physiological relevance, which, amongst other reasons, has been identified as c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31341280722cb024bb0b6fc30785744c
https://pubmed.ncbi.nlm.nih.gov/32297748
https://pubmed.ncbi.nlm.nih.gov/32297748
Autor:
Elena Del Favero, Alessandra Rossi, Eleonore Fröhlich, Jason T. McConville, Francesca Rossi, Ruggero Bettini, Irene Rossi, Francesca Buttini, Fabio Sonvico, Sarah Zellnitz
Publikováno v:
European journal of pharmaceutical sciences 113 (2018): 159–170. doi:10.1016/j.ejps.2017.10.024
info:cnr-pdr/source/autori:Rossi, Irene; Sonvico, Fabio; McConville, Jason T.; Rossi, Francesca; Froehlich, Eleonore; Zellnitz, Sarah; Rossi, Alessandra; Del Favero, Elena; Bettini, Ruggero; Buttini, Francesca/titolo:Nebulized coenzyme Q(10) nanosuspensions: A versatile approach for pulmonary antioxidant therapy/doi:10.1016%2Fj.ejps.2017.10.024/rivista:European journal of pharmaceutical sciences/anno:2018/pagina_da:159/pagina_a:170/intervallo_pagine:159–170/volume:113
info:cnr-pdr/source/autori:Rossi, Irene; Sonvico, Fabio; McConville, Jason T.; Rossi, Francesca; Froehlich, Eleonore; Zellnitz, Sarah; Rossi, Alessandra; Del Favero, Elena; Bettini, Ruggero; Buttini, Francesca/titolo:Nebulized coenzyme Q(10) nanosuspensions: A versatile approach for pulmonary antioxidant therapy/doi:10.1016%2Fj.ejps.2017.10.024/rivista:European journal of pharmaceutical sciences/anno:2018/pagina_da:159/pagina_a:170/intervallo_pagine:159–170/volume:113
Coenzyme Q(10) (CoQ(10)) is an antioxidant substance indicated as a dietary supplement which has been proposed as adjuvant in the treatment of cardiovascular disorders and cancer for its protective and immunostimulating activities. The aim of this wo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2536092c850342cd3db77fb9c437910
https://doi.org/10.1016/j.ejps.2017.10.024
https://doi.org/10.1016/j.ejps.2017.10.024
Publikováno v:
International Journal of Pharmaceutics. 535:402-409
Based on a computer tomographic scan of a human trachea, a modified induction port (mIP), for use with the Next Generation Cascade Impactor, was manufactured using 3D printing technology. Standard United States Pharmacopoeia IP (USPIP) was compared t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38e63c555caed2260247030ce3657fb3
https://doi.org/10.1016/j.ijpharm.2017.10.039
https://doi.org/10.1016/j.ijpharm.2017.10.039
Publikováno v:
Drug Development and Industrial Pharmacy. 44:868-871
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6cfe942f0ede4ea653aa2c98a5de016b
https://doi.org/10.1080/03639045.2017.1410331
https://doi.org/10.1080/03639045.2017.1410331
Publikováno v:
International Journal of Pharmaceutics. 514:407-419
Coenzyme Q10 (CoQ10) is a poorly-water soluble compound that is being investigated for the treatment of carcinomas. The aim of this study was to investigate the feasibility of preparing phospholipid-stabilized dispersions of the anticancer agent for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37e6c30065b41ba0dd4b1f8b4fdf83c8
https://doi.org/10.1016/j.ijpharm.2016.10.011
https://doi.org/10.1016/j.ijpharm.2016.10.011
Publikováno v:
Journal of Pharmacy and Pharmacology. 68:556-578
Objectives In this review paper, we explore the interaction between the functioning mechanism of different nebulizers and the physicochemical properties of the formulations for several types of devices, namely jet, ultrasonic and vibrating-mesh nebul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e648e72ebba69933fa06b2da9654af8a
https://doi.org/10.1111/jphp.12541
https://doi.org/10.1111/jphp.12541
Autor:
Masahiro Sakagimi, Anthony J. Hickey, Jason T. McConville, Phil J. Kuehl, Andrew Reginald Clark, Jayne E. Hastedt, Peter J. Mauser, William H. Doub, Jeffry G. Weers, Claus-Michael Lehr, Ralph Niven, Guenther Hochhaus, Per Bäckman
Publikováno v:
AAPS Open, Vol 2, Iss 1, Pp 1-20 (2016)
The Biopharmaceutics Classification System (BCS), developed in the 1990s for oral immediate release drugs, is utilized by R&D scientists and regulators to streamline product development and regulatory approval timelines. This elegant, science-based a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::379d2586398df4aa75f39d20636106c9
http://link.springer.com/article/10.1186/s41120-015-0002-x
http://link.springer.com/article/10.1186/s41120-015-0002-x